{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:07:52Z","timestamp":1771024072452,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005667","name":"Foundation for Research Support and Innovation of Santa Catarina State","doi-asserted-by":"publisher","award":["2021TR000442"],"award-info":[{"award-number":["2021TR000442"]}],"id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["405.538\/2021-9"],"award-info":[{"award-number":["405.538\/2021-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["403615\/2023-2"],"award-info":[{"award-number":["403615\/2023-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejphar.2024.177015","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T01:34:46Z","timestamp":1727314486000},"page":"177015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Cardiovascular effects of Roflumilast during sepsis: Risks or benefits?"],"prefix":"10.1016","volume":"983","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2529-2006","authenticated-orcid":false,"given":"Gustavo","family":"Ferreira Alves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3971-126X","authenticated-orcid":false,"given":"Junior Garcia","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Almeida","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4326-9566","authenticated-orcid":false,"given":"Gabrielle","family":"Delfrate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0264-7062","authenticated-orcid":false,"given":"Regina","family":"Sordi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil","family":"Assreuy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Eduardo","family":"da Silva-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8782-3496","authenticated-orcid":false,"given":"Massimo","family":"Collino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8935-4176","authenticated-orcid":false,"given":"Daniel","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177015_bib1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1164\/ajrccm.160.2.9810073","article-title":"Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach","volume":"160","author":"Annane","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2024.177015_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/08941939.2021.1908462","article-title":"Roflumilast as a potential therapeutic agent for cecal ligation and puncture-induced septic lung injury","volume":"35","author":"Bayraktutan","year":"2022","journal-title":"J. Invest. Surg."},{"key":"10.1016\/j.ejphar.2024.177015_bib3","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd1854","article-title":"Animal models of sepsis: setting the stage","volume":"4","author":"Buras","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2024.177015_bib4","first-page":"1335","article-title":"Influence of roflumilast on sepsis mice through the JAK\/STAT signaling pathway","volume":"23","author":"Chang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2024.177015_bib5","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.110.160176","article-title":"Regulation of 3\u2032,5\u2032-cAMP in preglomerular smooth muscle and endothelial cells from genetically hypertensive rats","volume":"56","author":"Cheng","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.177015_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11897-014-0247-z","article-title":"Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?","volume":"12","author":"Drosatos","year":"2015","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.ejphar.2024.177015_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc7922","article-title":"Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study","volume":"13","author":"Dubin","year":"2009","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejphar.2024.177015_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-03029-0","article-title":"Phosphodiesterase 4D promotes angiotensin II-induced hypertension in mice via smooth muscle cell contraction","volume":"5","author":"Fan","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejphar.2024.177015_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G\u2217Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.ejphar.2024.177015_bib10","first-page":"1008","volume":"vol. 97","author":"Feng","year":"2017"},{"key":"10.1016\/j.ejphar.2024.177015_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/SHK.0b013e3181818518","article-title":"Nitric oxide and vascular reactivity in sepsis","volume":"30","author":"Fernandes","year":"2008","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2024.177015_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173953","article-title":"Angiotensin II receptor type 1 blockade improves hyporesponsiveness to vasopressors in septic shock","volume":"897","author":"Fernandes","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177015_bib13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1124\/jpet.108.142034","article-title":"Late, but not early, inhibition of soluble guanylate cyclase decreases mortality in a rat sepsis model","volume":"328","author":"Fernandes","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2024.177015_bib14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/SHK.0000000000000152","article-title":"Phosphodiesterase 4 inhibition dose dependently stabilizes microvascular barrier functions and microcirculation in a rodent model of polymicrobial sepsis","volume":"41","author":"Flemming","year":"2014","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2024.177015_bib15","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1161\/CIRCULATIONAHA.112.114074","article-title":"Phosphoinositide 3-kinase \u03b3 protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases","volume":"126","author":"Ghigo","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.177015_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/fcp.12711","article-title":"Roflumilast improves resolution of sepsis-induced acute kidney injury by retarding late phase renal interstitial immune cells infiltration and leakage in urinary sediments","volume":"36","author":"Gupta","year":"2022","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177015_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2014.10.039","article-title":"Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats","volume":"746","author":"Jabaris","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177015_bib18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1124\/pr.120.019240","article-title":"The noncanonical pathway for in vivo nitric oxide generation: the nitrate-nitrite-nitric oxide pathway","volume":"72","author":"Kapil","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2024.177015_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-pharmtox-010716-104756","article-title":"Nanodomain regulation of cardiac cyclic nucleotide signaling by phosphodiesterases","volume":"57","author":"Kokkonen","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2024.177015_bib20","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0206-2022","article-title":"Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis","volume":"32","author":"Kolb","year":"2023","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.ejphar.2024.177015_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177015_bib22","doi-asserted-by":"crossref","first-page":"9753","DOI":"10.1073\/pnas.97.17.9753","article-title":"Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock","volume":"97","author":"Macarthur","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2024.177015_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.ejphar.2024.177015_bib24","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejphar.2024.177015_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/apha.12860","article-title":"Mind the gap: mechanisms regulating the endothelial barrier","volume":"222","author":"Radeva","year":"2018","journal-title":"Acta Physiol."},{"key":"10.1016\/j.ejphar.2024.177015_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nprot.2008.214","article-title":"Immunodesign of experimental sepsis by cecal ligation and puncture","volume":"4","author":"Rittirsch","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2024.177015_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2024.177015_bib28","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1113\/jphysiol.2012.232116","article-title":"Phosphodiesterase-4 inhibition as a therapeutic approach to treat capillary leakage in systemic inflammation","volume":"590","author":"Schick","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2024.177015_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archsurg.133.4.399","article-title":"The organs responsible for increased nitric oxide production after trauma-hemorrhage and resuscitation","volume":"133","author":"Smail","year":"1998","journal-title":"Arch. Surg."},{"key":"10.1016\/j.ejphar.2024.177015_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/cc10462","article-title":"Effects of changes in arterial pressure on organ perfusion during septic shock","volume":"15","author":"Thooft","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejphar.2024.177015_bib31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12871-022-01741-2","article-title":"Effect of norepinephrine infusion on hepatic blood flow and its interaction with somatostatin: an observational cohort study","volume":"22","author":"van Limmen","year":"2022","journal-title":"BMC Anesthesiol."},{"key":"10.1016\/j.ejphar.2024.177015_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/apha.14006","article-title":"cAMP: a master regulator of cadherin-mediated binding in endothelium, epithelium and myocardium","volume":"238","author":"Vielmuth","year":"2023","journal-title":"Acta Physiol."},{"key":"10.1016\/j.ejphar.2024.177015_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-4804(80)90037-2","article-title":"Sepsis and septic shock--a review of laboratory models and a proposal","volume":"29","author":"Wichterman","year":"1980","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ejphar.2024.177015_bib34","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/db21-0898","article-title":"Roflumilast-Mediated phosphodiesterase 4D inhibition reverses diabetes-associated cardiac dysfunction and remodeling: effects beyond glucose lowering","volume":"71","author":"Xu","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2024.177015_bib35","first-page":"1","article-title":"Roflumilast, a Phosphodiesterases-4 (PDE4) inhibitor, alleviates sepsis-induced acute kidney injury","volume":"26","author":"Xu","year":"2020","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.ejphar.2024.177015_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2021.10834","article-title":"Roflumilast, a type of phosphodiesterase 4 inhibitor, can reduce intestinal injury caused by sepsis","volume":"22","author":"Zhang","year":"2021","journal-title":"Exp. Ther. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T04:52:09Z","timestamp":1730436729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924007052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":36,"alternative-id":["S0014299924007052"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177015","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular effects of Roflumilast during sepsis: Risks or benefits?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177015"}}